Volume 57, Issue 3, Pages 675-688 (September 2012) Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)  René Adam, Vincent Karam, Valérie Delvart, John O’Grady, Darius Mirza, Jurgen Klempnauer, Denis Castaing, Peter Neuhaus, Neville Jamieson, Mauro Salizzoni, Stephen Pollard, Jan Lerut, Andreas Paul, Juan Carlos Garcia-Valdecasas, Fernando San Juan Rodríguez, Andrew Burroughs  Journal of Hepatology  Volume 57, Issue 3, Pages 675-688 (September 2012) DOI: 10.1016/j.jhep.2012.04.015 Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Number of LTs performed in each country, overall and living related liver transplantation (LRLT) (May 1968–December 2009). Journal of Hepatology 2012 57, 675-688DOI: (10.1016/j.jhep.2012.04.015) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Evolution of 93,634 LTs performed in Europe since May 1968. Arrows indicate the year the first LT was performed in indicated countries. ∗This decrease is owed to the fact that some centers did not yet send their updating further to the recent changes of the questionnaire. Journal of Hepatology 2012 57, 675-688DOI: (10.1016/j.jhep.2012.04.015) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Evolution of primary indications for LT in Europe (05.1968–12.2009). Journal of Hepatology 2012 57, 675-688DOI: (10.1016/j.jhep.2012.04.015) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 4 Mortality and re-LT. Percentage per period and cumulative proportions (01.1988–12.2009). Journal of Hepatology 2012 57, 675-688DOI: (10.1016/j.jhep.2012.04.015) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 5 Cause of death after LT of patients who survive beyond 6months. Journal of Hepatology 2012 57, 675-688DOI: (10.1016/j.jhep.2012.04.015) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 6 Evolution of patient survival in patients who survive beyond 6months. Journal of Hepatology 2012 57, 675-688DOI: (10.1016/j.jhep.2012.04.015) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 7 Patient survival according to year of LT. Journal of Hepatology 2012 57, 675-688DOI: (10.1016/j.jhep.2012.04.015) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 8 Patient survival according to indication for and year of LT. Journal of Hepatology 2012 57, 675-688DOI: (10.1016/j.jhep.2012.04.015) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 9 Evolution of donor age in Europe (05.1968–12.2009). Journal of Hepatology 2012 57, 675-688DOI: (10.1016/j.jhep.2012.04.015) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 10 Recipient graft survival according to donor age. Journal of Hepatology 2012 57, 675-688DOI: (10.1016/j.jhep.2012.04.015) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 11 Evolution of recipient age in Europe (05.1968–12.2009). Journal of Hepatology 2012 57, 675-688DOI: (10.1016/j.jhep.2012.04.015) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 12 Graft survival according to the number of LTs (01.1988–12.2009). Journal of Hepatology 2012 57, 675-688DOI: (10.1016/j.jhep.2012.04.015) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions